Correlation Between Takeda Pharmaceutical and Rafarma Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Rafarma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Rafarma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Rafarma Pharmaceuticals, you can compare the effects of market volatilities on Takeda Pharmaceutical and Rafarma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Rafarma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Rafarma Pharmaceuticals.
Diversification Opportunities for Takeda Pharmaceutical and Rafarma Pharmaceuticals
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Takeda and Rafarma is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Rafarma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rafarma Pharmaceuticals and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Rafarma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rafarma Pharmaceuticals has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Rafarma Pharmaceuticals go up and down completely randomly.
Pair Corralation between Takeda Pharmaceutical and Rafarma Pharmaceuticals
Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to under-perform the Rafarma Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical Co is 16.96 times less risky than Rafarma Pharmaceuticals. The stock trades about -0.11 of its potential returns per unit of risk. The Rafarma Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 5.50 in Rafarma Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of 3.20 from holding Rafarma Pharmaceuticals or generate 58.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Takeda Pharmaceutical Co vs. Rafarma Pharmaceuticals
Performance |
| Timeline |
| Takeda Pharmaceutical |
| Rafarma Pharmaceuticals |
Takeda Pharmaceutical and Rafarma Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Takeda Pharmaceutical and Rafarma Pharmaceuticals
The main advantage of trading using opposite Takeda Pharmaceutical and Rafarma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Rafarma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rafarma Pharmaceuticals will offset losses from the drop in Rafarma Pharmaceuticals' long position.| Takeda Pharmaceutical vs. Viatris | Takeda Pharmaceutical vs. Elanco Animal Health | Takeda Pharmaceutical vs. Zoetis Inc | Takeda Pharmaceutical vs. Emergent Biosolutions |
| Rafarma Pharmaceuticals vs. Holloman Energy Corp | Rafarma Pharmaceuticals vs. cbdMD Inc | Rafarma Pharmaceuticals vs. Evolus Inc | Rafarma Pharmaceuticals vs. CV Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |